Sarah Schram

Stock Analyst at William Blair

(n/a)
# 5,016
Out of 5,042 analysts
1
Total ratings
n/a
Success rate
-22.47%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sarah Schram

Denali Therapeutics
Jan 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $15.96
Upside: -